Navigation Links
Purinergic in Medical News

Renovis Announces Expiration of Hart-Scott-Rodino (HSR) 30-Day Waiting Period; Merger With Evotec on Track to Close in Early May, 2008

...ment of drugs for major medical needs in the areas of neurological and inflammatory diseases. The Company's proprietary research programs focus on the purinergic receptors, P2X3 and P2X7, for the potential treatment of pain and inflammatory diseases. In addition, Renovis has a worldwide collaboration and licens...

Renovis Announces Management Changes

... our portfolio of drug candidates for pain targeting members of the TRP and purinergic families of ligand-gated ion channels. Our team's work led to our collabora...ammatory diseases. The Company's proprietary research programs focus on the purinergic receptors, P2X3 and P2X7, for the potential treatment of pain and inflammat...
Purinergic in Biological Technology

Quantification of the Purinergic Receptor P2X3 using ICAT and Orthogonal 2D LC-MS/MS with an Ion Trap Mass Spectrometer

David Barnidge , Leo E. Bonilla , Gargi Choudhary Neuromics, Inc., Minneapolis, MN Thermo Finnigan, San Jose, CA ICAT Analysis The data prese...

Renovis Stockholders Approve Acquisition by Evotec

...ment of drugs for major medical needs in the areas of neurological and inflammatory diseases. The Company's proprietary research programs focus on the purinergic receptors, P2X3 and P2X7, for the potential treatment of pain and inflammatory diseases. In addition, Renovis has worldwide collaboration and license ...

Proxy Governance and Egan-Jones Recommend Renovis Shareholders Vote For Merger With Evotec

...ment of drugs for major medical needs in the areas of neurological and inflammatory diseases. The Company's proprietary research programs focus on the purinergic receptors, P2X3 and P2X7, for the potential treatment of pain and inflammatory diseases. In addition, Renovis has a worldwide collaboration and licens...

Glass Lewis & Co. Recommends Renovis Shareholders Vote For Merger With Evotec

...ment of drugs for major medical needs in the areas of neurological and inflammatory diseases. The Company's proprietary research programs focus on the purinergic receptors, P2X3 and P2X7, for the potential treatment of pain and inflammatory diseases. In addition, Renovis has a worldwide collaboration and licens...

Renovis Reports Fourth Quarter and Full Year 2007 Financial Results

...ment of drugs for major medical needs in the areas of neurological and inflammatory diseases. The Company's proprietary research programs focus on the purinergic receptors, P2X3 and P2X7, for the potential treatment of pain and inflammatory diseases. In addition, Renovis has a worldwide collaboration and licens...

Renovis Reports Third Quarter 2007 Financial Results

...ment of drugs for major medical needs in the areas of neurological and inflammatory diseases. The Company's proprietary research programs focus on the purinergic receptors, P2X3 and P2X7, for the potential treatment of pain and inflammatory diseases. In addition, Renovis has a worldwide collaboration and licens...

Renovis to Present at CIBC World Markets Healthcare Conference

...ment of drugs for major medical needs in the areas of neurological and inflammatory diseases. The Company's proprietary research programs focus on the purinergic receptors, P2X3 and P2X7, for the potential treatment of pain and inflammatory diseases. In addition, Renovis has worldwide collaboration and license ...

Monitoring Receptor-Mediated Changes in [Ca2+]i Using Single-Wavelength and Dual-Wavelength Indicators on the FlexStation Workstation

...s Health Science Center, Houston, Texas. ( http://www.tumor-gene.org/GPCR/gpcr.html ) 4. Strassheim, D. and Williams, C.L. (2000). P2Y 2 purinergic and M 3 Muscarinic Acetylcholine Receptors Activate Different Phospholipase C- Isoforms That Are Uniquely Susceptible to Protein Kinase C-dependent P...

Gq-coupled Receptor Assays Using FLEXstation

...ier, and J. M. Boeynaems. 1997. Cloning of a human purinergic P2Y receptor coupled to phospholipase C and adenyl... D. J. Adams, and B. J. Morris. 2000. Capacity for purinergic control of renin promoter via P2Y(11) receptor and.... 1998. ATP activates cAMP production via multiple purinergic receptors in MDCK-D1 epithelial cells. Blockade of...

Ca++-Induced G Protein Coupled Receptor (GPCR) Activation Monitored via Aequorin Luminescence in the LMax Microplate Luminometer (MaxLine Application Note #42)

...e curves for the activation of a Gqprotein-coupled purinergic receptor expressed endogenously in CHO cells. Thus... triphosphate (UTP) to activate the endogenous P2Y purinergic receptor. This receptor is known to be coupled to ...M coelenterazine(h), then exposed to UTP (a potent purinergic agonist), they responded with a rapid flash of lig...
Purinergic in Biological Products

Rabbit Anti-Human G-protein coupled purinergic receptor P2Y8 Polyclonal Antibody, Unconjugated from GenWay Biotech, Inc.

Description: G-protein coupled purinergic receptor P2Y8...
Company:GenWay Biotech, Inc.

Rabbit Anti-Human Purinergic Receptor P2Y12 Polyclonal Antibody, Unconjugated from IMGENEX

Description: Peptide-affinity Purified Polyclonal Antibody to Purinergic Receptor P2Y12...
Company:IMGENEX
Purinergic in Biological Dictionary

Adenosine

...ological actions and health effects. ... ADENOSINE , CAFFEINE AND ISCHEMIA/HYPOXIA. HEART DISEASE, CANCER AND CAFFEINE ... Adenosine can bind to purinergic receptors in different cell types where it can ... There is also evidence that adenosine inhibits calcium entry into the cell ... Learn about...
Other Tags
(Date:7/23/2014)... 2014 Researchers in Turkey say a ... yellow pigment in the spice turmeric, and an immunosuppressor ... lab. To read the full story on Surviving ... University in Ankara, Turkey pretreated mesothelioma cells ... them to two platinum-based chemotherapy drugs with promising results. ...
(Date:7/23/2014)... 23, 2014 Low enrollment and ... exchanges to come up with alternative means to ... myriad ways to accomplish this in the July ... Insurance Exchanges (HEX). , “We never expected the ... exchanges, Christopher Condeluci, an attorney at the law ...
(Date:7/23/2014)... 23, 2014 On July 19 and 20, ... the NBC 4 New York and New York Giants Health ... NJ. , The team, which included several hearing ... offered free hearing health screenings and answered any questions that ... hearing technology. , Also sponsored by the NFL Players ...
(Date:7/23/2014)... There is inherently nothing wrong with sweating. ... healthy enough to react to specific changes in the ... toxins and bacteria from the body in ways that ... do. , However, the social implications for people ... “excessive sweating”—are serious: since sweating itself often causes instances ...
(Date:7/23/2014)... Townsend Security, a leading authority in ... i security solutions now support two factor authentication. This ... of relying on passwords as their only authentication mechanism. ... Alliance Two Factor Authentication software with the following ... Alliance AES/400 – High performance, NIST validated AES ...
Breaking Medicine News(10 mins):Health News:New Research Finds Pretreatment of Mesothelioma Cells with These Two Compounds Boosts Chemotherapy Response, According to Surviving Mesothelioma 2Health News:New Research Finds Pretreatment of Mesothelioma Cells with These Two Compounds Boosts Chemotherapy Response, According to Surviving Mesothelioma 3Health News:Industry Observers Tell AIS They Predict Changes to Exchange User Fees, Platforms 2Health News:Industry Observers Tell AIS They Predict Changes to Exchange User Fees, Platforms 3Health News:The HearStrong Foundation Provides Hearing Healthcare Awareness at the NBC 4 New York and New York Giants Health & Fitness Expo 2014 2Health News:Beat Your Sweating Demons Review | The Problem With Excessive Sweating and Solving it Naturally – Vinamy.com 2Health News:Beat Your Sweating Demons Review | The Problem With Excessive Sweating and Solving it Naturally – Vinamy.com 3Health News:Townsend Security Brings Two Factor Authentication to Leading IBM i Security Solutions 2
(Date:7/23/2014)... for providing essential fatty acids and energy to ... has been concern that soybean-based emulsions could compromise ... its composition. Combination lipid emulsions based on triglyceride ... developed to address this concern. , However, researchers ... may be unwarranted, according to a review published ...
(Date:7/22/2014)... consists of both still images and video of ... research. Forty-four still images were chosen from more ... staff, and alumni representing more than 25 different ... than 50 submissions. , Zach Donnell, a graduate ... 2014 organizers, noted that the exhibit highlights the ...
(Date:7/22/2014)... (NASDAQ: AWRE ), a leading supplier of biometrics ... quarter ended June 30, 2014. Revenue for the ... 53% compared to $4.4 million in the same quarter last ... quarter of 2014 was $1.4 million compared to $0.5 million ... and operating income was driven by higher sales of software ...
Breaking Biology News(10 mins):Art of Science 2014 2Aware, Inc. Reports Second Quarter 2014 Financial Results 2Aware, Inc. Reports Second Quarter 2014 Financial Results 3Aware, Inc. Reports Second Quarter 2014 Financial Results 4Aware, Inc. Reports Second Quarter 2014 Financial Results 5Aware, Inc. Reports Second Quarter 2014 Financial Results 6Aware, Inc. Reports Second Quarter 2014 Financial Results 7
Other Contents